Why Shares of Gingko Bioworks Are Skyrocketing Today
Scared off from the stock after Scorpion Capital released a scathing report last week, investors are warming back up to Ginkgo Bioworks (NYSE: DNA). The catalyst for the rise today isn't just the shock of the critical report wearing off; it's favorable attention from Wall Street that's leading the bulls to click the buy button on this synthetic biology stock.
As of 2:47 p.m. EDT, shares of Gingko Bioworks are up 15.2%.
Image source: Getty Images.
Source Fool.com
